Buccal drug delivery system is a therapeutic option which delivers drugs through buccal mucosal lines (space between inner cheek and upper gingivae). Through buccal drug delivery system, the desired therapeutic dose of the drug gets immediately absorbed into plasma and the consistency of the concentration can be maintained throughout the duration of the treatment. Buccal dosage form may be of a) matrix type or b) reservoir type. In matrix type, the buccal path is configured in a matrix, comprising drugs, adhesives, and additives, all combined together. In reservoir type, the buccal path is fabricated in a reservoir system, consisting of a cavity for drug and adhesives separated from the drug. An impermeable surface is applied to the drug in order to direct drug delivery, reduce risk of patch deformation, and drug loss. 

The global buccal drug delivery system market is primarily driven by factors, such as, ease of drug administration and termination, low “first-pace effect”, availability of blood vessels, rapid absorption of drugs into plasma, rise in preference of macromolecules, including peptides, absorption enhancers, etc., increasing use of smaller molecules, and growing availability of non-ionized drugs. Furthermore, presence of major players in the market and availability of drugs is likely to boost the growth of the global buccal drug delivery system market during the forecast period. However, the market is anticipated to encounter challenges in terms of stringent regulatory conditions and law pertaining to intellectual property rights in the near future. Nevertheless, technological advancement and rise in mergers and acquisitions are expected to propel the global buccal drug delivery system market during the forecast period. 

In terms of formulation, the global buccal drug delivery system market can be segmented into sublingual films, tablets, and sprays. The market can be classified into insulin, nicotin, nifedipine, flubiprofen, and others, based on active ingredients. By end-user, the global buccal drug delivery system market can be categorized into hospitals, clinics, and others. 

Geographically, the global buccal drug delivery system market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the leading share of the global buccal drug delivery system market in 2017, owing to highly developed pharmaceutical industry, high rate of diagnosis and treatment of diseases, well-established health care infrastructure, presence of major players, high awareness of the product among end-users, and technological advancements in the region. In Europe, Germany, France, and the U.K. accounted for major share of the buccal drug delivery system market in 2017, while the market in Italy and Spain is expected to witness significant growth during the forecast period. Highly developed health care industry, high rate of diagnosis and treatment of diseases, availability of drugs, presence of major players, and participation of small companies (particularly from Germany) in the market are the key factors which supported Germany, France, and the U.K. to capture the leading share of the buccal drug delivery systems market in Europe in 2017. Developing health care infrastructure and technological advancements are likely to propel the growth of the buccal drug delivery systems market in Italy and Spain in the next few years. 

In Asia, China and Japan held the dominant share of the buccal drug delivery system market in 2017. The buccal drug delivery system market in India is estimated to grow at a significant CAGR in the near future, owing to the developing pharmaceutical industry, presence of well-established domestic players, and intense competition between domestic and international players in the country. Underdeveloped pharmaceutical industry and lack of awareness about buccal drug delivery system are likely to hamper the growth of the buccal drug delivery systems market in Latin America and Middle East & Africa during the forecast period. 

Key players operating in the global buccal drug delivery system market include Ethypharm, Cynapsus, Ardea Biosciences, Applied Pharma Research, BioDelivery Sciences, Cynapsus, Actavis, and Endo Pharmaceutical.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Buccal Drug Delivery System Market

Pre Book